BKNG — Booking Holdings Inc.

Q2 2026 beat consensus across the board and analysts are broadly positive (average target $233.47, no sell ratings), but the market is also digesting conservative Q3 guidance of only 3-5% room-night growth and a lowered full-year gross bookings outlook. The stock was down 3.03% on 2026-08-27, RSI is neutral at 49.93, and price is below the 20-day SMA, so near-term sentiment is cautious despite a fundamentally positive backdrop.

Revenue growth is clearly decelerating from mid-teens YoY (Q1 2026 +16.2%, Q4 2025 +16.1%, Q3 2025 +12.7%) to +8.15% in Q2 2026. Q2 2026 revenue of $7.352B was still a strong quarter, and operating income of $2.5B produced a 34.0% operating margin. Net income jumped to $1.95B from $895M a year earlier, helped by operating leverage and cleaner comparisons, and TTM FCF is roughly $9.5B. The trend is a growth normalization, not a collapse: margins, cash conversion, and buyback intensity remain excellent, but the double-digit growth era is giving way to high-single-digit growth.

BKNG looks fair to cheap versus its own history. As of 2026-08-27, trailing P/E is 22.35x, forward P/E using next-FY EPS of $10.452 is about 19.4x, and P/S is 5.56x versus a 5-year average of 6.64x. PEG is 0.399, and the stock trades well below its 5-year average P/E of 40.25x. Negative book equity makes P/B and D/E meaningless, but ROIC of ~50.8% and a TTM FCF yield of roughly 6.1% confirm real earning power. Overall: attractive relative to its own history, though not a statistically cheap deep-value stock.

At $202.56, the market is essentially paying ~19.4x forward earnings for a business guided to mid-single-digit room-night growth. That means the stock is not pricing in a big rebound, but rather a mature, high-quality cash compounder. If Q3 prints at the high end of guidance and AI-driven cost savings flow through, the stock could re-rate toward the $233-240 area. If growth decelerates further, the low multiple offers limited protection because forward estimates would be cut along with growth.

As of 2026-08-27, RSI(14) is 49.93, neutral. The stock is 2.53% below its 20-day SMA (~$207.8), 5.91% above its 50-day SMA (~$191.3), and 8.95% above its 200-day SMA (~$185.9). That is a range-bound consolidation in the upper half of the 52-week range ($150.14-$226.63) after a strong recovery off the lows. No oversold bounce setup yet; patient entry would be better on a pullback toward the 50-day SMA or on a convincing close back above the 20-day.

• Geopolitical conflict in the Middle East disrupting long-haul travel capacity and raising airfares.
• Consumer travel demand normalizing after the post-COVID boom, with room-night growth decelerating to mid-single digits.
• Generative AI is both a cost-saving tool for Booking and a long-term threat to traditional OTA search traffic.
• High interest rates pressure discretionary spending, though BKNG's large cash position and A-rated balance sheet provide insulation.
• Resilient U.S. domestic and intra-European travel is offsetting weaker long-haul international demand.

• Q3 2026 earnings (late Oct/early Nov 2026) - whether room-night growth lands in the 3-5% guidance range or beats.
• Citi 2026 Global TMT Conference (Aug 25-28, 2026) commentary on late-summer travel demand trends.
• AI transformation program savings raised to ~$650M, supporting further margin expansion.
• Continued outsized capital returns: $3.7B buyback in Q2 2026 plus a growing quarterly dividend.

• Generative AI platforms disintermediating OTA search and booking traffic over time.
• Deeper travel demand deceleration or a consumer spending downturn, especially in long-haul international.
• Middle East conflict escalation further disrupting flight capacity and booking volumes.
• Negative stockholders' equity of -$10.8B and $18.2B long-term debt leave less balance-sheet cushion if cash flow weakens.
• Intense competition from Google, direct hotel booking, Airbnb, and Expedia pressuring take rates and growth.

BKNG is a best-in-class travel cash compounder with ~35% operating margins, ~50% ROIC, and roughly $9.5B of trailing free cash flow, yet as of 2026-08-27 it trades at a discount to its own historical multiples. The main bear arguments - AI disruption and demand normalization - are real, but the current price already reflects a fairly muted growth outlook. Long-term risk/reward is skewed positive, though near-term guidance suggests no urgent catalyst for a sharp re-rate.

I applied a 23.0x forward P/E to next-fiscal-year consensus EPS of $10.452. That multiple is a premium to the market but a discount to BKNG's 5-year average P/E, justified by its ~35% operating margin, ~50% ROIC, and exceptional FCF conversion, while tempered by decelerating mid-single-digit room-night growth.